Literature DB >> 29572693

Human chorionic gonadotropin serum levels following ovulation triggering and IVF cycle outcome.

Yossi Mizrachi1,2, Eran Horowitz3,4, Jacob Farhi3,4, David Levran3,4, Arieh Raziel3,4, Ariel Weissman3,4.   

Abstract

PURPOSE: The clinical significance of serum hCG levels after ovulation triggering was studied previously with conflicting results. Our aim was to study the correlation of hCG levels on the day after ovulation triggering using recombinant hCG (r-hCG) with treatment outcome.
METHODS: A prospective observational study of all fresh IVF/ICSI cycles in a single medical center, between January 2015 and June 2016, was performed. hCG serum levels were obtained 10-12 h following ovulation triggering with 250 mcg r-hCG. Clinical and laboratory outcome parameters were compared between cycles with serum hCG above and below median level. A multivariate regression analysis was performed in order to study the association between hCG levels and live birth rate, after controlling for confounders.
RESULTS: Overall, 326 cycles were included. Median serum hCG level was 91.35 IU/L. hCG levels were lower as age and BMI were higher (p = 0.004, p < 0.001, respectively). The study groups did not differ with regard to clinical pregnancy rate (p = 0.14), live birth rate (p = 0.09), fertilization rate (p = 0.45), or metaphase II oocyte rate (p = 0.68). On multivariate regression analysis, hCG level was not associated with live birth (aOR 0.99, 95% CI 0.98-1.005), after controlling for patient's age and BMI.
CONCLUSIONS: hCG levels on the day after ovulation triggering with 250 mcg r-hCG are inversely correlated with patient age and BMI. However, they are not correlated with any clinical or laboratory outcome parameter. Therefore, testing for hCG levels after ovulation induction seems futile and cannot be recommended.

Entities:  

Keywords:  BMI; Human chorionic gonadotropin; IVF; Outcome

Mesh:

Substances:

Year:  2018        PMID: 29572693      PMCID: PMC5984896          DOI: 10.1007/s10815-018-1165-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  27 in total

1.  Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration.

Authors:  A Weissman; S Lurie; Y Zalel; R Goldchmit; Z Shoham
Journal:  Gynecol Endocrinol       Date:  1996-08       Impact factor: 2.260

2.  Low plasma levels of hCG after 10,000-IU hCG injection do not reduce the number or maturation of oocytes recovered in patients undergoing assisted reproduction.

Authors:  S al-Hassan; S Fishel; S Fleming; S Thornton
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

3.  Relationship between serum human chorionic gonadotrophin levels and body mass index in women undergoing in vitro fertilisation cycles.

Authors:  Petros Stefanis; Sangeeta Das; Emil Barsoum-Derias; Charles Kingsland; Iwan Lewis-Jones; Rafet Gazvani
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-10-02       Impact factor: 2.435

4.  The empty follicle syndrome: a pharmaceutical industry syndrome.

Authors:  F Zegers-Hochschild; E Fernández; A Mackenna; C Fabres; E Altieri; T Lopez
Journal:  Hum Reprod       Date:  1995-09       Impact factor: 6.918

5.  The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program.

Authors:  H I Abdalla; M Ah-Moye; P Brinsden; D L Howe; F Okonofua; I Craft
Journal:  Fertil Steril       Date:  1987-12       Impact factor: 7.329

6.  The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF-ICSI.

Authors:  Jianjun Zhou; Shanshan Wang; Bin Wang; Junxia Wang; Hua Chen; Ningyuan Zhang; Yali Hu; Haixiang Sun
Journal:  Reprod Biomed Online       Date:  2015-03-09       Impact factor: 3.828

7.  Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme.

Authors:  M Wikland; J Borg; A S Forsberg; A H Jakobsson; P Svalander; U Waldenström
Journal:  Hum Reprod       Date:  1995-07       Impact factor: 6.918

8.  Body mass index is inversely related to intrafollicular HCG concentrations, embryo quality and IVF outcome.

Authors:  Douglas T Carrell; Kirtly P Jones; C Matthew Peterson; Vincent Aoki; Benjamin R Emery; Bruce R Campbell
Journal:  Reprod Biomed Online       Date:  2001       Impact factor: 3.828

9.  Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles.

Authors:  Laura Detti; Mohamed F M Mitwally; Anuradha Rode; Frank D Yelian; Michael Kruger; Michael P Diamond; Elizabeth E Puscheck
Journal:  Fertil Steril       Date:  2007-04-06       Impact factor: 7.329

10.  Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women.

Authors:  Carina C W Chan; Ernest H Y Ng; Maureen M Y Chan; Oi Shan Tang; Estella Y L Lau; William S B Yeung; Pak-Chung Ho
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

View more
  2 in total

1.  The effect of intrauterine hCG injection before embryo transfer on pregnancy rate in frozen embryo transfer cycles.

Authors:  Moghadaseh Jahanshahi; Ashraf Aleyasin; Marzieh Aghahosseini; Aida Najafian; Maryam Shabani Nashtaei; Sedigheh Hosseinimousa
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

2.  Impact of Serum Human Chorionic Gonadotropin and Luteinizing Hormone Receptor Expression to Oocyte Maturation Rate: A Study of Controlled Ovarian Stimulation.

Authors:  Hilwah Nora; Budi Wiweko; R Muharam; Grace Wangge; Andon Hestiantoro; Gita Pratama; Achmad Kemal Harzif; Sarah Chairani Zakirah
Journal:  J Hum Reprod Sci       Date:  2020-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.